Selected Recent Cross-Border Transactions

in its agreement to be acquired by

Jan 2021
$4.6 billion

in its acquisition of

Jan 2021
€1.24 billion

in the sale of its commercial, clinical and research-stage oncology portfolio to

Dec 2020
$2 billion

in its acquisition by

Dec 2020
$39 billion

in its all-stock merger with

Nov 2020
$44 billion

in its Up-C transaction with its shareholders,

Nov 2020

in its acquisition of

Nov 2020
$2.75 billion

in its agreement to acquire

Nov 2020
$11.6 billion

in its acquisition by

Nov 2020
$1.35 billion

in the acquisition of Watford Holdings Ltd., by Arch Capital Group Ltd., Warburg Pincus and Kelso & Company

Nov 2020
$700 million

in its sale of a 34.9% stake in Scientific Games to institutional investors including Caledonia

Sep 2020
$1 billion

in the spin-off of its eye health business

Aug 2020
Page 1 of 7